Back to top
more

CVS Health (CVS)

(Real Time Quote from BATS)

$67.47 USD

67.47
202,275

+0.02 (0.03%)

Updated Apr 30, 2024 09:50 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 7% (234 out of 251)

Industry: Retail - Pharmacies and Drug Stores

Better trading starts here.

Zacks News

Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.

Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now?

Smart Beta ETF report for RSPH

Here's Why You Should Retain CVS Health (CVS) Stock for Now

Investors are optimistic about CVS Health's (CVS) strength in Health Care Benefits business arm and stable solvency position.

Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock

Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.

Should Invesco S&P 100 Equal Weight ETF (EQWL) Be on Your Investing Radar?

Style Box ETF report for EQWL

CVS Health (CVS) Q3 Earnings Surpass Estimates, Margins Up

Robust sales growth across all three operating segments drove CVS Health's (CVS) third-quarter results.

CVS Health (CVS) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for CVS Health (CVS) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Arhaus (ARHS) Gears Up to Post Q3 Earnings: Is a Beat in Store?

Arhaus' (ARHS) third-quarter 2023 results are likely to have gained from robust demand for products, strength in the showroom and e-commerce channels and normalization of the supply chain.

Wall Street Analysts Look Bullish on CVS Health (CVS): Should You Buy?

According to the average brokerage recommendation (ABR), one should invest in CVS Health (CVS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know

CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Overstock (OSTK) to Report Q3 Earnings: What's in Store?

Overstock's (OSTK) third-quarter 2023 results are likely to reflect strength in the Bed Bath & Beyond brand. However, weakening consumer engagement in the housing market is likely to have been a concern.

What's in Store for STMicroelectronics (STM) in Q3 Earnings?

STMicroelectronics' (STM) third-quarter results are likely to reflect product portfolio strength and end-market momentum despite macroeconomic challenges.

CVS Health (CVS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

These 2 Retail and Wholesale Stocks Could Beat Earnings: Why They Should Be on Your Radar

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

What to Note Ahead of Deckers Outdoor's (DECK) Q2 Earnings

Deckers Outdoor's (DECK) Q2 results might have been hurt by softness across its brands, rising expenses and macroeconomic headwinds. Its customer-centric product and marketing strategies are likely to have been tailwinds.

CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know

In the latest trading session, CVS Health (CVS) closed at $68.97, marking a -0.03% move from the previous day.

CVS Health (CVS) to Report Q3 Earnings: What's in the Cards?

CVS Health (CVS) Q3 revenues will likely benefit from growth in specialty pharmacy and brand inflation and increased prescription and front store volume.

Is Invesco S&P 100 Equal Weight ETF (EQWL) a Strong ETF Right Now?

Smart Beta ETF report for EQWL

CVS Health (CVS) Stock Moves -1.28%: What You Should Know

CVS Health (CVS) closed at $71.09 in the latest trading session, marking a -1.28% move from the prior day.

Brian Bolan headshot

Bear of the Day: Walgreens Boots Alliance (WBA)

Competition heated up and Walgreens got the boot.

Shaun Pruitt headshot

Is There Enough Value to Buy CVS or Best Buy Stock for a Rebound?

When it comes to value investing, Best Buy (BBY) and CVS (CVS) stock should certainly be on investors' radars but is it time to buy?

These 2 Retail and Wholesale Stocks Could Beat Earnings: Why They Should Be on Your Radar

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

CVS Health (CVS) Stock Moves -0.63%: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $69.25, marking a -0.63% move from the previous day.

Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?

CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Here's Why You Should Retain CVS Health (CVS) Stock for Now

Investors continue to remain optimistic about CVS Health (CVS) due to the new acquisitions and the strong execution of the pharmacy business.